1. Home
  2. OABI vs PSEC Comparison

OABI vs PSEC Comparison

Compare OABI & PSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OmniAb Inc.

OABI

OmniAb Inc.

N/A

Current Price

$4.66

Market Cap

773.1M

Sector

Health Care

ML Signal

N/A

Logo Prospect Capital Corporation

PSEC

Prospect Capital Corporation

N/A

Current Price

$1.26

Market Cap

771.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
OABI
PSEC
Founded
2012
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
773.1M
771.4M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
OABI
PSEC
Price
$4.66
$1.26
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $8.33
N/A
AVG Volume (30 Days)
1.3M
★ 8.3M
Earning Date
10-30-2026
11-04-2026
Dividend Yield
N/A
★ 33.33%
EPS Growth
6.56
★ 104.44
EPS
N/A
★ N/A
Revenue
★ $18,666,000.00
N/A
Revenue This Year
$94.10
N/A
Revenue Next Year
$30.33
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.35
$1.25
52 Week High
$5.45
$3.13

Technical Indicators

Market Signals
Indicator
OABI
PSEC
Relative Strength Index (RSI) 42.52 26.81
Support Level $4.53 N/A
Resistance Level $5.43 $2.33
Average True Range (ATR) 0.32 0.12
MACD -0.05 -0.01
Stochastic Oscillator 4.76 1.22

Price Performance

Historical Comparison
OABI
PSEC

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

About PSEC Prospect Capital Corporation

Prospect Capital Corp is a financial services company that mainly lends to and invests in middle market privately-held companies. It is a closed-end investment company. Its investment objective is to generate both current income and long-term capital appreciation. It has single operating and reporting segment.

Share on Social Networks: